"With ePAT now deploying Artificial Intelligence in commercial healthcare applications this agreement supports further collaboration and R&D opportunities for both companies to provide personalized, safe, and secure healthcare solutions that are unique in their market” says Tim Llewellynn, CEO of nViso.
The statement above clearly shows that the EPT/nViso management are setting the stage for further app development, very much looking forward to seeing more detail emerge on the direction here, the pain recognition apps for non verbal patients will certainly be the first but AI and healthcare are the wider focus. Blue skys ahead.
"With ePAT now deploying Artificial Intelligence in commercial...
-
- There are more pages in this discussion • 111 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
